NCT04579380 2025-12-19
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Seagen Inc.
Phase 2 Active not recruiting
Seagen Inc.
Shasqi, Inc.
University of California, San Diego
Leap Therapeutics, Inc.
M.D. Anderson Cancer Center